Pedro V Baptista Selected Research

Pedro V Baptista Research Topics

Disease

48	Neoplasms (Cancer) 04/2024 - 02/2010
10	Colorectal Neoplasms (Colorectal Cancer) 03/2024 - 08/2014
8	Carcinoma (Carcinomatosis) 03/2024 - 10/2018
4	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 11/2021 - 02/2010
3	Lung Neoplasms (Lung Cancer) 04/2024 - 10/2013
3	Breast Neoplasms (Breast Cancer) 02/2023 - 01/2017
3	Inflammation (Inflammations) 01/2023 - 05/2015
3	Adenocarcinoma 02/2021 - 05/2015
3	Ovarian Neoplasms (Ovarian Cancer) 01/2021 - 10/2018
2	Hypoxia (Hypoxemia) 01/2023 - 01/2022
2	Hyperthermia 01/2021 - 09/2020
2	Leukemia 01/2019 - 01/2017
2	Philadelphia Chromosome 11/2018 - 07/2016
2	Malaria 08/2015 - 01/2012
1	Adenocarcinoma of Lung 04/2024
1	Prostatic Neoplasms (Prostate Cancer) 02/2023
1	Glioblastoma (Glioblastoma Multiforme) 12/2022
1	Brain Neoplasms (Brain Tumor) 12/2022
1	Melanoma (Melanoma, Malignant) 11/2022
1	Ischemia 01/2022
1	Reperfusion Injury 01/2022
1	Disease Progression 11/2021
1	Alzheimer Disease (Alzheimer's Disease) 03/2021
1	Colonic Neoplasms (Colon Cancer) 01/2021
1	Necrosis 02/2020
1	B-Cell Lymphoma (Lymphoma, B Cell) 10/2019
1	Neoplasm Metastasis (Metastasis) 01/2019
1	Circulating Neoplastic Cells 01/2019

Drug/Important Bio-Agent (IBA)

26	GoldIBA 07/2021 - 02/2010
9	Doxorubicin (Adriamycin)FDA LinkGeneric 03/2024 - 01/2017
7	Proteins (Proteins, Gene)FDA Link 01/2023 - 08/2014
5	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022 - 10/2019
4	Biomarkers (Surrogate Marker)IBA 04/2024 - 01/2019
4	DNA (Deoxyribonucleic Acid)IBA 03/2022 - 09/2015
3	MicroRNAs (MicroRNA)IBA 04/2024 - 03/2013
3	Tumor Biomarkers (Tumor Markers)IBA 03/2022 - 06/2014
3	RNA (Ribonucleic Acid)IBA 03/2013 - 02/2010
2	CopperIBA 03/2024 - 09/2015
2	SteroidsIBA 02/2023 - 02/2014
2	Testosterone (Sustanon)FDA Link 02/2023 - 02/2014
2	ErbB Receptors (EGF Receptor)IBA 11/2021 - 10/2017
2	Cisplatin (Platino)FDA LinkGeneric 06/2021 - 10/2020
2	Peptides (Polypeptides)IBA 03/2021 - 01/2017
2	SilverIBA 01/2021 - 10/2019
2	Nucleic AcidsIBA 07/2020 - 06/2017
2	Cetuximab (Erbitux)FDA Link 11/2019 - 06/2014
2	LigandsIBA 10/2018 - 09/2015
2	NanoconjugatesIBA 06/2017 - 10/2013
2	OligonucleotidesIBA 01/2017 - 08/2014
2	Small Interfering RNA (siRNA)IBA 05/2015 - 10/2013
1	Indicators and Reagents (Reagents)IBA 04/2024
1	Complementary DNA (cDNA)IBA 04/2024
1	Bovine Serum AlbuminIBA 03/2024
1	Estradiol (Delestrogen)FDA LinkGeneric 02/2023
1	Coloring Agents (Dyes)IBA 02/2023
1	4,4- difluoro- 4- bora- 3a,4a- diaza- s- indacene (BODIPY)IBA 02/2023
1	1,10-phenanthrolineIBA 01/2023
1	RutheniumIBA 01/2023
1	Cytostatic AgentsIBA 01/2023
1	Protons (Proton)IBA 12/2022
1	BoronIBA 12/2022
1	TriterpenesIBA 11/2022
1	AnionsIBA 11/2022
1	Liposomes (Liposome)IBA 01/2022
1	QuercetinIBA 01/2022
1	TriazolesIBA 01/2022
1	Coordination ComplexesIBA 01/2022
1	AcridinesIBA 01/2022
1	Phosphotransferases (Kinase)IBA 11/2021
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2021
1	Transforming Growth Factor beta (TGF-beta)IBA 11/2021
1	NF-kappa B (NF-kB)IBA 11/2021
1	beta CateninIBA 11/2021
1	Amyloid beta-PeptidesIBA 03/2021
1	TrabectedinIBA 01/2021
1	OxindolesIBA 01/2021
1	MetalsIBA 01/2021
1	OxidesIBA 01/2021
1	GraphiteIBA 01/2021
1	Oxygen (Dioxygen)IBA 10/2020
1	HalogensIBA 10/2020
1	IronIBA 09/2020
1	FormazansIBA 02/2020
1	Annexin A5IBA 02/2020
1	Antineoplastic Agents (Antineoplastics)IBA 11/2019
1	Circulating Tumor DNAIBA 01/2019
1	SaltsIBA 01/2019
1	Protein Isoforms (Isoforms)IBA 11/2018
1	AcetyleneIBA 10/2018
1	PropaneIBA 10/2018
1	Diacetyl (Biacetyl)IBA 10/2018
1	nonaneIBA 10/2018
1	tesmilifene (DPPE)IBA 10/2018

Therapy/Procedure

18	Therapeutics 01/2023 - 11/2015
8	Drug Therapy (Chemotherapy) 01/2023 - 01/2017
4	Precision Medicine 02/2023 - 11/2014
3	Lasers (Laser) 10/2020 - 11/2017
2	Photothermal Therapy 01/2017 - 11/2014
1	Radiotherapy 12/2022
1	Induced Hyperthermia (Thermotherapy) 10/2020